JANUX THERAPEUTICS INC (JANX) Stock Cash Flow
NASDAQ:JANX - Nasdaq - US47103J1051 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -77.74M | -68.99M | -58.29M | -63.06M | -32.67M | |||
| Depreciation Amortization | 2.05M | 2.06M | 1.96M | 840.00K | 110.00K | |||
| Change In Working Capital | 4.62M | 685.00K | -6.55M | 4.28M | 8.84M | |||
| Other non cash items | 25.08M | 22.43M | 12.32M | 15.02M | 6.74M | |||
| OPERATING CASH FLOW | -46.00M | -43.81M | -50.58M | -42.92M | -16.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -533.00K | -359.00K | -1.85M | -6.45M | -1.48M | |||
| Other Investing Activity | -484.14M | -257.66M | -39.34M | 64.71M | -339.48M | |||
| INVESTING CASH FLOW | -484.68M | -258.02M | -41.19M | 58.27M | -340.96M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 391.62M | 713.24M | 59.55M | 500.00K | 182.36M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 204.17M | |||
| FINANCING CASH FLOW | 391.62M | 713.24M | 59.55M | 500.00K | 386.52M | |||
| CHANGE IN CASH | -139.06M | 411.40M | -32.22M | 15.85M | 28.58M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -46.00M | -43.81M | -50.58M | -42.92M | -16.98M | |||
| Capital Expenditure | -533.00K | -359.00K | -1.85M | -6.45M | -1.48M | |||
| FREE CASH FLOW | -46.53M | -44.17M | -52.42M | -49.37M | -18.46M | |||
All data in USD